WHO ICTRP trial
investigate Prevalence of lymphedema after breast neoplasm surgery
IRCT20200909048672N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20200909048672N1 |
|---|---|
| Public title | investigate Prevalence of lymphedema after breast neoplasm surgery |
| Scientific title | comparing Prevalence of lymphedema after Axillary Reverse Mapping by methylen blue or without methylen blue in patients with breast neoplasm |
| Primary sponsor | Esfahan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Condition 1: breast cancer. Condition 2: lymphedema. Malignant neoplasm of breast Postmastectomy lymphedema syndrome;I97.2 |
| Interventions | Intervention 1: first we inject methylen blue to patients in this group and with colored path that methylen blue makes , axillary lymph node mapping will be done. then using this mapping sentinel lymph node will be detected and dissected… |
| Registration date | Dec 6, 2020 |
| Target size | 160 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: